Antimicrobial Susceptibility of Campylobacter isolates in the Capital of North Macedonia

1. Kaakoush N, Castaño-Rodríguez N, Mitchell HM, et al. Global epidemiology of Campylobacter infection. Clin Microbiol Rev 2015; 28(3): 687–720.10.1128/CMR.00006-15446268026062576Search in Google Scholar

2. EFSA, (European Food Safety Authority), ECDC (European Centre for Disease Prevention and Control), 2013. The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2011. EFSA Journal 2013; 11(4): 3129, 250 pp.10.2903/j.efsa.2013.3129Search in Google Scholar

3. CDC, (Centers for Disease Control and Prevention). Preliminary Food Net data on the incidence of infection with pathogens transmitted commonly through food-10 states, 2009. Morb Mortal Wkly Rep 2009; 58(13): 333–7.Search in Google Scholar

4. Zollner-Schweitz I, Krause R. Therapy of acute gastroenteritis: role of antibiotics. Clin Microbiol Infect 2015; 21: 744–749.10.1016/j.cmi.2015.03.00225769427Search in Google Scholar

5. The United Nations Children’s Fund (UNICEF)/World Health Organization (WHO). Diarrhoea: Why Children Are Still Dying and WhatCan Be Done, 2009.Search in Google Scholar

6. European Centre for Disease Prevention And Control. EU protocol for harmonised monitoring of antimicrobial resistance in human Salmonella and Campylobacter isolates – June 2016. Stockholm: ECDC; 2016.Search in Google Scholar

7. Stroni GP, Dhimolea MM, Pipero PS, et al. A study of the epidemiology and etiology of acute gastroenteritis in adult patients presenting at the infectious diseases hospital in Tirana, Albania. Balkan Med J 2014; 31(3): 196–201.10.5152/balkanmedj.2014.13142429996225625016Search in Google Scholar

8. Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 2001; 32(8): 1201–1206.1128381010.1086/31976011283810Search in Google Scholar

9. Man SM. The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol 2011; 8(12): 669–685.10.1038/nrgastro.2011.19122025030Search in Google Scholar

10. Walker CL, Black RE. Diarrhea morbidity and mortality in older children, adolescents and adults. Epidemiol Infect 2010; 138(9): 1215–26.10.1017/S095026881000059220307341Search in Google Scholar

11. Cheng AC, McDonald JR, Thielman NM, et al. Infectious diarrhea in developed and developing countries. J Clin Gastroenterol 2005; 39(9): 757–73.10.1097/01.mcg.0000177231.13770.0716145337Open DOISearch in Google Scholar

12. Dryden MS, Gabb RJ, Wright SK. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis 1996; 22(6): 1019–25.10.1093/clinids/22.6.10198783703Open DOISearch in Google Scholar

13. Hooper DC, Wolfson JS. Fluoroquinolone antimicrobial agents. N Engl J Med 1991; 324: 384–394.10.1056/NEJM1991020732406061987461Search in Google Scholar

14. Gaunt PN, Piddock LJV. Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study. J Antimicrob Chemother 1996; 37(4): 747–57.10.1093/jac/37.4.7478722540Search in Google Scholar

15. Nielsen HL, Ejlertsen T, Engberg J, et al. High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study. Clin Microbiol Infect 2013; 19(5): 445–50.10.1111/j.1469-0691.2012.03852.x22512739Open DOISearch in Google Scholar

16. Moore JE, Barton MD, Blair IS, et al. The epidemiology of antibiotic resistance in Campylobacter. Microbes Infect 2006; 8(7): 1955–1966.10.1016/j.micinf.2005.12.03016716632Open DOISearch in Google Scholar

17. Emonet S, Redzepi B, Riat A, et al. Colitis due to Campylobacter jejuni/coli. Ceftriaxone is not effective. J Gerontol Geriatr Res 2017; 6: 426.10.4172/2167-7182.1000426Search in Google Scholar

18. EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control), 2017. The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015. EFSA Journal 2017; 15(2): 4694, 212 pp.10.2903/j.efsa.2017.4694700988332625402Search in Google Scholar

19. Hakanen A, Jousimies-Somer H, Siitonen A, et al. Fluoroquinolone resistance in Campylobacter jejuni isolates in travellers returning to Finland: association of ciprofloxacin resistance to travel destination. Emerg Infect Dis 2003; 9(2): 267–270.10.3201/eid0902.020227290194312604004Open DOISearch in Google Scholar

20. Vlieghe ER, Jacobs JA, Van Esbroeck M, et al. Trends of norfloxacin and erythromycin resistance of Campylobacter jejuni/Campylobacter coli isolates recovered from international travellers, 1994 to 2006. J Travel Med 2008; 15(6): 419–25.10.1111/j.1708-8305.2008.00236.x19090796Search in Google Scholar